The Greater Cannabis Company, Inc. (GCAN)
Stock Price:
$0.0032 USD
0.0000 (-5.88%)
Updated Oct 22, 2020 3:59 PM EDT - Market closed
Key Info
| Market Cap |
379,645 |
| Revenue (ttm) |
55,164 |
| Net Income (ttm) |
-1.33M |
| Shares Out |
118.64M |
| EPS (ttm) |
-0.02 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 22, 2020 |
| Last Price |
$0.0032 |
| Previous Close |
$0.0034 |
| Change ($) |
0.0000 |
| Change (%) |
-5.88% |
| Day's Open |
0.0029 |
| Day's Range |
0.0029 - 0.0033 |
| Day's Volume |
7,422,538 |
| 52-Week Range |
0.0028 - 0.07 |
More Stats
| Market Cap |
379,645 |
| Enterprise Value |
704,141 |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
118.64M |
| Float |
112.99M |
| EPS (basic) |
-0.04 |
| EPS (diluted) |
-0.02 |
| FCF / Share |
-0.01 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
1.80 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
6.88 |
| PB Ratio |
n/a |
| Revenue |
55,164 |
| Operating Income |
-443,169 |
| Net Income |
-1.33M |
| Free Cash Flow |
-292,187 |
| Net Cash |
-324,496 |
| Net Cash / Share |
0.00 |
| Gross Margin |
-119.65% |
| Operating Margin |
-803.37% |
| Profit Margin |
-2,413.90% |
| FCF Margin |
-529.67% |
| ROA |
-101.30% |
| ROE |
n/a |
| ROIC |
131.50% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|
| Revenue | 0.01 | 0.10 | - | - |
| Revenue Growth | -92.53% | 45533.97% | - | - |
| Gross Profit | - | 0.10 | - | - |
| Operating Income | -0.53 | -0.19 | -0.62 | -0.10 |
| Net Income | -1.65 | -0.84 | -0.81 | -0.10 |
| Shares Outstanding | 34.98 | 29.96 | 27.98 | 26.91 |
| Earnings Per Share | -0.05 | -0.03 | -0.03 | - |
| Operating Cash Flow | -0.29 | -0.10 | -0.04 | - |
| Free Cash Flow | -0.29 | -0.10 | -0.04 | - |
| Cash & Equivalents | 0.02 | 0.06 | 0.00 | - |
| Total Debt | 0.66 | 0.32 | 0.11 | 0.10 |
| Net Cash / Debt | -0.63 | -0.27 | -0.11 | -0.10 |
| Assets | 0.05 | 0.15 | - | - |
| Liabilities | 1.60 | 0.71 | 0.39 | 0.11 |
| Book Value | -1.55 | -0.56 | -0.39 | -0.11 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
The Greater Cannabis Company, Inc. |
| Country |
United States |
| Employees |
2 |
| CEO |
Aitan Zacharin |
Stock Information
| Ticker Symbol |
GCAN |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Drug Manufacturers—Specialty & Generic |
| Unique Identifier |
OTCMKTS: GCAN |
Description
The Greater Cannabis Company, a biopharmaceutical company, focuses on the development and commercialization of technology for transmucosal delivery of legal medical or recreational cannabis and cannabinoids. The company intends to commercialize the technology by sublicensing or partnering with licensed producers, distributors, processors, consumer product, and pharmaceutical companies in the legal cannabis and CBD industries to bring the product to the North American market in legal medical and recreational cannabis and CBD segments. The Greater Cannabis Company, Inc. is based in Baltimore, Maryland.